EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 24 / No 3 (2018) J Oral Med Oral Sug, 24 3 (2018) 107-111 References
Open Access
Issue
J Oral Med Oral Sug
Volume 24, Number 3, 2018
Page(s) 107 - 111
Section Article original / Original article
DOI https://doi.org/10.1051/mbcb/2018001
Published online 10 October 2018
  1. Bogucki Z, Kownacka M. Clinical aspects of the use of botulinum toxin type a in the treatment of dysfunction of the masticatory system. Adv Clin Exp Med 2016;25:569–573. [CrossRef] [PubMed] [Google Scholar]
  2. Orthlieb JDJ, Chossegros C, Cheynet F, Giraudeau A, Mantout B. Cadre diagnostique des Dysfonctionnements de l'Appareil Manducateur (DAM). Inf Dent 2004;19:1196–1203. [Google Scholar]
  3. Johansson A, Unell L, Carlsson GE, Söderfeldt B, Halling A. Gender difference in symptoms related to temporomandibular disorders in a population of 50-year-old subjects. J Orofac Pain 2003;17:29–35. [PubMed] [Google Scholar]
  4. Slade GD, Bair E, Greenspan JD, Dubner R, Fillingim RB, Diatchenko L et al. Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study. J Pain Off J Am Pain Soc 2013;14:T20. [CrossRef] [Google Scholar]
  5. Wieckiewicz M, Boening K, Wiland P, Shiau Y-Y, Paradowska-Stolarz A. Reported concepts for the treatment modalities and pain management of temporomandibular disorders. J Headache Pain [Internet]. [cité 3 avr 2017];16. Disponible sur: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671990. [Google Scholar]
  6. Durham VA. Temporomandibular disorders (TMDs): an update and management guidance for primary care from the UK specialist interest group in orofacial pain and TMDs (USOT) [Internet]. Royal College of surgeons of England: 2013 [cité 3 avr 2017]. Disponible sur: https://www.escholar.manchester.ac.uk/uk-ac-man-scw:223426. [Google Scholar]
  7. Cheynet F, Orthlieb JD, Saint-Pierre F. Orthèses (Gouttières) occlusales : indications dans les Dysfonctionnements Temporo-Mandibulaires (DTM): recommandations de Bonne Pratique. Société Française de Stomatologie, Chirurgie Maxillo-Faciale et Chirurgie Orale [Internet]. 2016. Disponible sur: http://www.sfscmfco.fr/wp-content/uploads/2017/01/Orthèses-Gouttières-occlusales−Indications-dans-les-Dysfonctionnements-Temporo-Mandibulaires-DTM.pdf. [Google Scholar]
  8. Tighe AP, Schiavo G. Botulinum neurotoxins: mechanism of action. Toxicon 2013;67:87–93. [CrossRef] [PubMed] [Google Scholar]
  9. Fedorowicz Z, van Zuuren EJ, Schoones J. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev 2013;9:CD007510. [Google Scholar]
  10. Persaud R, Garas G, Silva S, Stamatoglou C, Chatrath P, Patel K. An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. JRSM Short Rep 2013;4:10. [CrossRef] [PubMed] [Google Scholar]
  11. Freund B, Schwartz M, Symington JM. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 1999;57:916–920. [CrossRef] [PubMed] [Google Scholar]
  12. Freund B, Schwartz M. The use of botulinum toxin for the treatment of temporomandibular disorder. Oral Health 1998;88:32–37. [PubMed] [Google Scholar]
  13. Song PC, Schwartz J, Blitzer A. The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Oral Dis 2007;13:253–260. [CrossRef] [PubMed] [Google Scholar]
  14. Freund BJ, Schwartz M. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A. Headache J Head Face Pain 2002;42:1033–1037. [CrossRef] [Google Scholar]
  15. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio J Craniomandib Pract 2008;26:126–135. [Google Scholar]
  16. Lindern von JJ, Niederhagen B, Bergé S, Appel T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg 2003;61:774–778. [CrossRef] [PubMed] [Google Scholar]
  17. Chen Y-W, Chiu Y-W, Chen C-Y, Chuang S-K. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. Int J Oral Maxillofac Surg 2015;44:1018–1026. [CrossRef] [PubMed] [Google Scholar]
  18. Freund B, Schwartz M, Symington JM. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 2000;38:466–471. [CrossRef] [PubMed] [Google Scholar]
  19. Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg 2008;66:1644–1651. [CrossRef] [PubMed] [Google Scholar]
  20. Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg 2013;51:199–205. [CrossRef] [Google Scholar]
  21. Lee SJ, McCall WD, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. Am J Phys Med Rehabil 2010;89:16–23. [CrossRef] [PubMed] [Google Scholar]
  22. Ernberg M, Hedenberg-Magnusson B, List T, S vensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain 2011;152:1988–1996. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.